DGA S.A. Logo

DGA S.A.

Consulting, training, and EU-funded project services for public and private organizations.

DGA | WAR

Overview

Corporate Details

ISIN(s):
PLDGA0000019 (+1 more)
LEI:
259400DTDT4GWZLEL890
Country:
Poland
Address:
Poznań Towarowa 37, 61-896 Poznań
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

DGA S.A. is a consulting and advisory group with over 35 years of experience in providing innovative solutions and professional guidance. The company's core activities include business and management consulting, corporate restructuring advisory, and the implementation of comprehensive training programs for both individuals and organizations. DGA specializes in acquiring and executing projects co-financed by external sources, including European Union funds. The firm actively fosters innovation through incubation and acceleration programs for startups and social initiatives. Its diverse service portfolio also covers labor market activation, educational development programs, and specialized coaching. DGA serves a broad clientele, ranging from micro to large enterprises, public institutions, and non-governmental organizations.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-30 17:17
Interim Report
Oświadczenie Zarządu
Polish 1.0 MB
2025-09-30 17:17
Audit Report / Information
Raport z przeglądu sprawozdania finansowego DGA S.A.
Polish 411.5 KB
2025-09-30 17:17
Management Discussion and Analysis
Sprawozdanie Zarządu z działalności DGA S.A. za I półrocze 2025 r
Polish 1.5 MB
2025-09-30 17:17
Annual / Quarterly Financial Statement
Sprawozdanie finansowe DGA S.A. za I półrocze 2025 r.
Polish 1.8 MB
2025-07-31 14:15
Regulatory News Service
Zawiadomienie o zejściu poniżej progu 5% ogólnej liczby głosów w Spółce - Conte…
Polish 1.8 KB
2025-07-30 15:04
Major Shareholding Notification
Zawiadomienie akcjonariusza
Polish 78.4 KB
2025-07-30 15:04
Major Shareholding Notification
Zawiadomienie o przekroczeniu progu 5% ogólnej liczby głosów w Spółce - Content…
Polish 1.2 KB
2025-07-29 13:56
Regulatory News Service
Otrzymanie podpisanego egzemplarza umowy znaczącej - Content (PL)
Polish 475 bytes
2025-07-17 15:22
Regulatory News Service
Podpisanie znaczącej umowy - Content (PL)
Polish 1.3 KB
2025-05-29 17:26
Management Discussion and Analysis
Informacje uzupełniające i komentarz Zarządu
Polish 1.5 MB
2025-05-29 17:26
Quarterly Report
Jednostkowe sprawozdanie finansowe DGA S.A. za I kw. 2025 r.
Polish 1.7 MB
2025-05-22 16:05
Declaration of Voting Results & Voting Rights Announcements
Lista akcjonariuszy posiadających co najmniej 5% liczby głosów na Zwyczajnym Wa…
Polish 1.0 KB
2025-05-22 15:56
Post-Annual General Meeting Information
Treść podjętych uchwał
Polish 204.0 KB
2025-05-22 15:56
Post-Annual General Meeting Information
Treść uchwał podjętych przez Zwyczajne Walne Zgromadzenie w dniu 22 maja 2025 r…
Polish 751 bytes
2025-04-24 15:10
Environmental & Social Information
Podpisanie umowy na realizację projektu. pt. "Zielona gospodarka - szkolenia i …
Polish 1.0 KB

Automate Your Workflow. Get a real-time feed of all DGA S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for DGA S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Korean CRO offering end-to-end clinical trial services for pharma & bio ventures.
South Korea 187660
HYUNDAI BIOSCIENCE CO., LTD. Logo
Clinical-stage biotech developing safer antiviral & anticancer drugs via advanced drug delivery systems.
South Korea 048410
IMGT Corporation Limited Logo
Develops a drug delivery platform using ultrasound and nanotech for oncology.
South Korea 456570
Immunic AG Logo
Developing oral therapies for autoimmune diseases like multiple sclerosis and celiac disease.
United States of America IMUX
Operates one of Japan's largest ad networks and a 'Furusato Nozei' tax donation website.
Japan 6535
INBIOGEN CO.,Ltd Logo
Data mining, bioinformatics, and virtual assistance for the life sciences industry.
South Korea 101140
Incross Co.,Ltd. Logo
A digital marketing firm offering data-driven ad solutions via proprietary AI and video platforms.
South Korea 216050
INEST,Inc. Logo
Offers ASP solutions and HR support to businesses and sells mobile devices to consumers.
Japan 7111
Innate Pharma Logo
Clinical-stage biotech developing NK cell-engaging antibodies for cancer immunotherapy.
France IPH
Innovation Inc. Logo
Drives B2B growth via digital media, IT solutions, M&A advisory, and venture capital.
Japan 3970

Talk to a Data Expert

Have a question? We'll get back to you promptly.